Ferroptosis and Multiple Sclerosis: How FTMT Links Blood Proteins to Personalized Neurology
Multiple sclerosis (MS) is a chronic autoimmune and neurodegenerative disease in which immune-mediated inflammation damages myelin, axons, and neurons in the central nervous system. The article focuses on a timely question: whether disturbances in iron metabolism and ferroptosis—an iron-dependent, lipid-peroxidation-driven form of regulated cell death—help explain MS susceptibility and progression. Framed within predictive, preventive, and personalized medicine, the study asks whether blood-circulating proteins and ferroptosis-related genes can reveal genetically supported biomarkers or therapeutic targets for MS.
Ferroptosis as a mechanistic bridge in MS
Ferroptosis is biologically relevant to MS because iron accumulation, oxidative stress, mitochondrial dysfunction, and lipid peroxidation are all implicated in demyelinating lesions and neurodegeneration. In MS, excess iron may promote reactive oxygen species formation, damaging oligodendrocytes and neurons. The authors propose that ferroptosis-related genes may sit at the intersection of immune activation, iron homeostasis, and neurodegenerative injury, making them attractive candidates for understanding why some individuals are more vulnerable to MS-related tissue damage.
Study design: using Mendelian randomization to infer causality
Rather than relying on conventional observational correlations, the study used two-sample Mendelian randomization (MR), a genetic epidemiology method that uses genetic variants as instrumental variables to test whether an exposure is likely to causally influence an outcome. The authors integrated MS genome-wide association data from the International Multiple Sclerosis Genetics Consortium, circulating protein data from UKB-PPP and deCODE, and ferroptosis-related genes curated from FerrDb. The workflow shown in Figure 1 on page 3 illustrates this logic: genetic instruments were used to connect circulating proteins, ferroptosis mediators, and MS risk while testing assumptions about confounding and pleiotropy.
FTMT emerges as the central ferroptosis-related gene
Among 159 ferroptosis-related genes tested against MS risk, 13 showed initial associations, but only FTMT, encoding mitochondrial ferritin, remained significant after multiple-testing correction. The reported effect estimate suggested a protective association, with FTMT linked to lower MS risk. This is biologically plausible because FTMT helps sequester mitochondrial iron, limits iron-driven oxidative injury, and may reduce lipid peroxidation. The forest plot in Figure 2 on page 5 visually places FTMT among the strongest ferroptosis-related signals after correction.
Circulating proteins linked to MS risk
The authors then examined protein quantitative trait loci to identify circulating proteins genetically associated with MS. After Bonferroni correction, they identified 21 MS-associated proteins, including immune-related and inflammatory proteins such as CD8A, GZMA, KIR2DL3, HLA-E, CCL19, LTB, and TNFRSF4, as well as proteins with roles in tissue remodeling, metabolism, or neural biology. Figure 3 on page 5 summarizes these associations in a forest plot, distinguishing proteins with genetically predicted protective versus risk-enhancing effects on MS.
FTMT mediates protein effects on MS pathogenesis
A key contribution of the study is its mediation MR analysis. The authors found that several circulating proteins appeared to influence MS risk partly through FTMT. Specifically, FTMT mediated estimated proportions of the MS-related effects of CD8A at 17.6%, CFB at 9.0%, ENPP6 at 9.5%, GZMA at 22.9%, KIR2DL2 at 17.4%, KIR2DL3 at 16.9%, and TNXB at 13.2%. Figure 5 on page 6 presents these mediation pathways, supporting the idea that immune and circulating protein signals may converge on mitochondrial iron regulation and ferroptosis biology.
Implications, limitations, and future directions
This article positions FTMT as a potentially important molecular node linking circulating immune proteins, ferroptosis regulation, and MS susceptibility. For predictive medicine, these protein-gene relationships could inform biomarker panels for MS risk or activity. For preventive medicine, they suggest that iron handling, lipid peroxidation, and mitochondrial oxidative stress may be intervention points before irreversible neurodegeneration occurs. For personalized medicine, FTMT-centered pathways could help stratify patients whose disease biology is more ferroptosis-driven. However, the findings remain genetic and computational: most datasets were European-ancestry based, MR depends on instrumental-variable assumptions, and experimental validation in cells, animal models, and patient cohorts will be essential before FTMT or these proteins can be translated into clinical tools.
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Xiong, Y., Yang, D., & Cai, S. (2025). The predictive, preventive, and personalized medicine of multiple sclerosis: ferroptosis and circulating proteins. Neurological Research, 1-9.
